(E)-(((3-nitroallyl)oxy)methyl)benzene | 194807-63-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (E)-(((3-nitroallyl)oxy)methyl)benzene
• 英文别名: [(E)-3-nitroprop-2-enoxy]methylbenzene
• CAS: 194807-63-1
• 化学式: C₁₀H₁₁NO₃
• 分子量: 193.202
• InChiKey: SHWBLDVEOSVNNZ-QPJJXVBHSA-N

物化性质

• 沸点：
  328.5±30.0 °C(Predicted)
• 密度：
  1.149±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  55
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)-(((3-nitroallyl)oxy)methyl)benzene 在 吡啶 、 C₂₈H₂₈F₆N₄S 、 氯化铵 、 三乙胺 、 锌 作用下， 以 乙醇 、 二氯甲烷 、 水 、 甲苯 为溶剂， 反应 172.0h， 生成 (S)-1-(1-(benzyloxy)-3-(p-nitrophenylsulfonamido)propan-2-yl)naphthalen-2-yl trifluoromethanesulfonate
  参考文献：
  名称：

  A new enantioselective approach to the core structure of hypoxia selective prodrugs related to the duocarmycins

  摘要：

  The indoline scaffold of hypoxia selective prodrugs of DNA-alkylating agents related to the duocarmycin natural products was synthesized via an enantioselective Friedel-Crafts alkylation. Easily accessible starting materials and good stereoselectivity in the alkylation step provide an enantioselective synthesis of the DNA-alkylating subunit. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2011.10.105
• 作为产物：
  描述：

  顺-1,4-二苄氧基-2-丁烯 在 臭氧 、 四甲基胍 作用下， 以 二氯甲烷 、 甲苯 为溶剂， 反应 2.92h， 生成 (E)-(((3-nitroallyl)oxy)methyl)benzene
  参考文献：
  名称：

  Solid supported Hayashi–Jørgensen catalyst as an efficient and recyclable organocatalyst for asymmetric Michael addition reactions

  摘要：

  A comparison of three different catalytic systems for the efficient, asymmetric synthesis of N-({(3R,4R)-4-[(benzyloxy)methyllpyrrolidin-3-yl]methyl)-N-(2-methylpropyl)benzenesulfonamide 1 (BZN) is described. The presented strategy is based on the organocatalytic Michael addition of aldehyde 2 to trans-nitroalkene 3, and subsequent reductive cyclization. High yields, enantio-, and diastereoselectivities were achieved in the Michael addition by application of a POSS- or Wang resin-supported Hayashi-Jorgensen catalyst. (C) 2017 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetasy.2017.10.016

文献信息

• [EN] ASYMMETRIC MICHAEL AND ALDOL ADDITION USING BIFUNCTIONAL CINCHONA-ALKALOID-BASED CATALYSTS<br/>[FR] ADDITIONS ASYMETRIQUES DE MICHAEL ET D'ALDOL UTILISANT DES CATALYSEURS BIFONCTIONNELS A BASE DE CINCHONINE
  申请人：UNIV BRANDEIS

  公开号：WO2005121137A1

  公开（公告）日：2005-12-22

  One aspect of the present invention relates to quinine-based and quinidine-based catalysts. Another aspect of the invention relates to a method of preparing a derivatized quinine-based or quinidine-based catalyst comprising 1) reacting quinine or quinidine with 5 base and a compound that has a suitable leaving group, and 2) converting the ring methoxy group to a hydroxy group. Another aspect of the present invention relates to a method of preparing a chiral, non-racemic compound from a prochiral electron-deficient alkene or azo compound or prochiral aldehyde or prochiral ketone, comprising the step of: reacting a prochiral electron-deficient alkene or azo compound or prochiral aldehyde or prochiral 10 ketone with a nucleophile in the presence of a catalyst; thereby producing a chiral, non racemic compound; wherein said catalyst is a derivatized quinine or quinidine. Another aspect of the present invention relates to a method of kinetic resolution, comprising the step of reacting racemic chiral alkene with a nucleophile in the presence of a derivatized quinine or quinidine.

  本发明的一个方面涉及基于奎宁和奎宁的催化剂。发明的另一个方面涉及一种制备衍生奎宁或奎宁催化剂的方法，包括1）将奎宁或奎宁与5碱和具有适当离去基团的化合物反应，以及2）将环甲氧基转化为羟基。本发明的另一个方面涉及一种从前手性电子亏缺烯烃或偶氮化合物或前手性醛或前手性酮制备手性、非拉克米化合物的方法，包括以下步骤：在催化剂存在下，将前手性电子亏缺烯烃或偶氮化合物或前手性醛或前手性酮与亲核试剂反应；从而产生手性、非拉克米化合物；其中所述催化剂是衍生奎宁或奎宁。本发明的另一个方面涉及一种动力学分辨的方法，包括在衍生奎宁或奎宁存在下，将拉克米手性烯烃与亲核试剂反应的步骤。
• Cu^I -Catalysed Enantioselective Alkyl 1,4-Additions to (<i>E</i> )-Nitroalkenes and Cyclic Enones with Phosphino-Oxazoline Ligands
  作者：Minkyeong Shin、Minji Gu、Sung Soo Lim、Min-Jae Kim、JuHyung Lee、HyeongGyu Jin、Yun Hee Jang、Byunghyuck Jung

  DOI：10.1002/ejoc.201800476

  日期：2018.6.29

  New phosphino‐oxazoline ligands have been developed, and the ligands have been used for Cu‐catalysed enantioselective conjugate additions to (E)‐nitroalkenes.

  已开发出新的膦基-恶唑啉配体，该配体已被用于铜催化的（E）-硝基烯烃的铜对映体选择性共轭加成反应。
• A Selective and Practical Synthesis of Nitroolefins
  作者：Irina Jovel、Saisuree Prateeptongkum、Ralf Jackstell、Nadine Vogl、Christoph Weckbecker、Matthias Beller

  DOI：10.1002/adsc.200800509

  日期：2008.11.3

  straightforward and general synthesis of nitroolefins from nitric oxide (NO) and olefins is presented. The direct nitration of aromatic olefins, allyl compounds, and acrylic acid derivatives proceeds smoothly at room temperature with high regioselectivity and good yields. The advantages of this novel procedure compared to established nitration procedures are demonstrated.

  提出了由一氧化氮（NO）和烯烃直接合成硝基烯烃的方法。芳族烯烃，烯丙基化合物和丙烯酸衍生物的直接硝化在室温下可进行，并具有较高的区域选择性和良好的收率。与建立的硝化程序相比，该新颖程序的优势得到了证明。
• [EN] AZACARBAZOLE BTK INHIBITORS<br/>[FR] INHIBITEURS DE BTK AZACARBAZOLE
  申请人：MERCK SHARP & DOHME

  公开号：WO2016164284A1

  公开（公告）日：2016-10-13

  The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula (I), or pharmaceutically acceptable salts thereof, wherein CH, R1, R1a, R1b, R2, R3, and the subscripts m1, m2, p, q, and t are as set forth herein. The present invention also provides pharmaceutical compositions comprising these compounds and their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula (I) in the treatment of Btk mediated disorders.

  本发明提供了根据式（I）提供的Bruton's酪氨酸激酶（Btk）抑制剂化合物，或其药学上可接受的盐，其中CH、R1、R1a、R1b、R2、R3以及下标m1、m2、p、q和t如本文所述。本发明还提供了包括这些化合物的药物组合物以及它们在治疗中的应用。具体而言，本发明涉及使用式（I）的Btk抑制剂化合物治疗Btk介导的疾病。
• Stereoselective Access to -Nitro Carboxylates, Precursors for Highly Functionalized -Lactams
  作者：Christian Meisterhans、Anthony Linden、Manfred Hesse

  DOI：10.1002/hlca.200390063

  日期：2003.3

  γ-lactams, is presented. (+)-(R)-3-Hydroxy-3-phenylpropanoic acid (20) and its ethyl ester 25 were prepared from (+)-L-mandelic acid (21). Condensation of 20 with pivalaldehyde furnished the novel enantiomerically pure 1,3-dioxan-4-one 17, the absolute configuration of which was established by X-ray crystal-structure analysis. Treating the lithium enolate of 17 with the nitro alkene 18 led, in a Michael-type

  提出了对映体纯的硝基衍生物31和epi - 32的直接合成，它们是用于合成高度官能化的γ-内酰胺的特别有用的中间体。由（+）-L-扁桃酸（21）制备（+）-（R）-3-羟基-3-苯基丙酸（20）及其乙酯25。20与新戊醛的缩合提供了新颖的对映体纯的1,3-二恶烷-4-酮17，其绝对构型是通过X射线晶体结构分析确定的。处理17的烯醇锂与硝基烯烃18一起，以迈克尔型加成反应，得到两种非对映异构产物的1：1混合物。添加的立体控制仅限于内酯功能旁边的新型立体发生中心。当用18处理25的烯醇锂时，观察到相同的选择性，但化学收率较低。当一个异构体选择性地环化成硝基内酯31，而另一个异构体以羟基酯epi - 32的形式分离时，在合成序列中稍后会很容易地分离出这些异构体。外消旋的相对构型外延- 32 可以通过X射线晶体结构分析确定。